Literature DB >> 12996103

Evaluation of l-hydrazinophthalazine (apresoline) in treatment of hypertensive disease.

R D TAYLOR, H P DUSTAN, A C CORCORAN, I H PAGE.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; SYMPATHOLYTICS/therapeutic use

Mesh：

Substances：

Year:  1952        PMID： 12996103     DOI： 10.1001/archinte.1952.00240120009002

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN： 0888-2479


× No keyword cloud information.
  5 in total

1.  [Effect of peroral prolonged therapy with 1,4-dihydrazinophthalazine on circulation and reflex changes in dogs].

Authors:  V EHRLICH; K FRONKOVA; L SLEGR
Journal:  Arch Kreislaufforsch       Date:  1958-09

2.  [Effect of hypotensive nepresol on heart volume and vascular resistance in hypertensive patients].

Authors:  H SCHUMANN
Journal:  Klin Wochenschr       Date:  1953-08-01

3.  Autoradiographic study of the distribution of [3H]- and [14C]-hydrallazine in the rat.

Authors:  J R Baker; G R Bullock; I H Williamson
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

4.  A comparison of the effects of hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the treatment of hypertension.

Authors:  E S ORGAIN; C L RAST; H A SIEBER
Journal:  Trans Am Clin Climatol Assoc       Date:  1953

5.  The clinical evaluation and management of hypertension.

Authors:  A V GOODYER; E ROSENTHAL; C A JAEGER
Journal:  Yale J Biol Med       Date:  1955-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.